PDE4: Studies have shown that phosphodiesterase (PDE) inhibitors altered inflammatory pathways stimulated in AD and could be considered as a therapeutic target for a non‐steroid based topical treatment for AD.144, 145, 146. The gene discussed is ALDH7A1; the disease is Alzheimer disease.